M. W. F. van den Hoogen, D. A. Hesselink, W. J. van Son, W. Weimar and L. B. Hilbrands Treatment of Steroid-Resistant Acute Renal Allograft Rejection With Alemtuzumab American Journal of Transplantation 13
Article first published online: 21 NOV 2012 | DOI: 10.1111/j.1600-6143.2012.04328.x
The authors show that alemtuzumab might be equally effective and as safe as antithymocyte globulin for the treatment of steroid-resistant renal allograft rejections, but with a significantly lower incidence of infusion-related side effects, the possibility to administer alemtuzumab subcutaneously, and lower costs. See editorial by Kirk on page 9.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf